Electrogenic sodium bicarbonate cotransporter 1 (NBCe1)

Electrogenic sodium bicarbonate cotransporter 1 (NBCe1), encoded by the SLC4A4 gene, is a basolateral membrane transporter that mediates the co-transport of sodium (Na⁺) and bicarbonate (HCO₃⁻) ions across the plasma membrane, typically with a stoichiometry of 1 Na⁺ to 3 HCO₃⁻[4]. It plays a pivotal role in the reabsorption of filtered bicarbonate in the renal proximal tubule, thereby maintaining systemic acid–base homeostasis[1][7][9]. In the brain, NBCe1 is primarily expressed in astrocytes and contributes to regulation of extracellular pH[4]. NBCe1 is also present in the eye, pancreas, and airway epithelia, with distinct splice variants (NBCe1-A in kidney, NBCe1-B in pancreas, NBCe1-C in brain) adapted for tissue-specific functions[4][7]. Mutations in SLC4A4 disrupt transporter function, causing autosomal recessive proximal renal tubular acidosis and often coexisting ocular and neurological abnormalities[1][2][7]. There is expanding evidence implicating SLC4A4 in airway pH regulation and as a potential therapeutic target in some forms of migraine and tumor cell biology[5][6]. Experimental inhibitors such as S0859 target NBCe1 in research settings, though selective clinical inhibitors are not yet in use[6]. Notably, widespread tissue expression presents therapeutic challenges, as globally reducing NBCe1 function risks systemic metabolic, ophthalmic, and neurological complications. This target is correctly specified as a clinically relevant membrane transporter involved in acid–base balance and linked to human disease[1][2][4][7].

Other names

SLC4A4NBCNBC1NBCe1-ANBCe1-BNBCe1-CSodium bicarbonate cotransporterkNBC1pNBCHNBC1KNBCNBC2SLC4A5hhNMC

Inhibition of sodium bicarbonate co-transport, leading to altered pH regulation and bicarbonate transport (for inhibitors like S0859)